Cargando…
State of the European Union’s early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020–2022)
BACKGROUND: Early notification of impending drug shortages is essential for mitigating or preventing shortages. Since 2019 pharmaceutical companies in the European Union (EU) and European Economic Area (EEA) must notify authorities of drug shortages at least two months in advance. This study’s aim w...
Autores principales: | Ravela, Reko, Airaksinen, Marja, Lyles, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629130/ https://www.ncbi.nlm.nih.gov/pubmed/37936250 http://dx.doi.org/10.1186/s40545-023-00646-w |
Ejemplares similares
-
National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA
por: Ravela, Reko, et al.
Publicado: (2022) -
The enforceability of the trade and sustainable development chapters of the European Union’s free trade agreements
por: van ‘t Wout, Demy
Publicado: (2021) -
Immigration within European Union – Does health immigration make a difference in analgesic use?
por: Väänänen, Minna H., et al.
Publicado: (2006) -
Price differentials of oral triptans in eight European Union countries
por: Folino-Gallo, Pietro, et al.
Publicado: (2003) -
Facilitators and barriers in implementing medication safety practices
across hospitals within 11 European Union countries
por: Linden-Lahti, Carita, et al.
Publicado: (2019)